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Abstract Continuous models of tumor-induced angiogenesis have been 
discussed and numerical simulations of one model have been carried out 
and the figures corresponding to various types of behaviors of the biological 
event have been shown. Actual dynamics of the biological process can be 
visualized with the help of figures generated. We also discussed the anti- 
angiogenesis strategy by identifying factors responsible for angiogenesis, and 
targeting such factors to control the process. The prevalent drugs along with 
their mathematical parameters have been discussed.
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1. InTrOduCTIOn
Cancer is one of the major reasons of mortality and morbidity all over the world. The developed countries are spending huge amount of money in cancer research. It is estimated that 1 out of 8 persons in the developed 
countries and 1 out of 20 persons in the developing countries are suffering 
from cancer. Several eminent personalities including Edward Lorenz, the 
Father of Chaos, and Steve Jobs, founder of i-phone, lost their life to cancer. In 
India alone, nearly 11 lakh people suffer from cancer and about 5 lakh people 
die due to it every year. Scientists are working hard to find a pattern of cell 
behavior and proliferation of transformed cells in different types of cancers.
It is noteworthy that besides many scientific tools, the subject of mathematical 
modeling and numerical analysis have also played a significant role in cancer 
research. Balding and McElwain (1985) developed a mathematical model for 
tumor-induced capillary growth. Chaplain and Stuart (1991) modeled diffusion 
of chemical secreted by tumor into the surrounding tissue. A noteworthy 
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discussed some classical growth equations and interplay between tumor and 
surrounding tissue during cancer growth and therapy. Sheratt and Chaplain 
(2001) extensively discussed the early development of solid tumor using 
mathematical modeling. Swanson (2003) reviewed mathematical modeling of 
brain tumors both untreated and treated after having undergone chemotherapy 
or surgical resection. Gerisch and Chaplain (2008) formulated a continuum 
model of cancer cell invasion of tissue which incorporates the processes of 
cell-cell and cell-matrix invasion.
Bryne and Chaplain (1995) developed a mathematical model for tumor 
angiogenesis, wherein a tumor recruits blood vessels from the neighboring 
vasculature, thereby getting nutrients and a mode for metastasis.
Balding and McElwain (1985) solved this model which was developed 
by the method of lines, which converts the modeled equations into a larger 
system of ordinary differential equations. Bryne and Chaplain (1995) solved 
the model with the help of NAG FORTRAN routine DO3PGF.
In this paper, we discuss three models of tumor induced angiogenesis and 
carry out the numerical simulations of tumor angiogenesis model of Bryne 
and Chaplain (1995) using the Mathematica software. We have shown the 
figures in case of successful angiogenesis, unsuccessful angiogenesis and slow 
angiogenesis. We further discuss anti – angiogenesis strategy, by identifying 
the various factors responsible for angiogenesis, and targeting these factors to 
control and slow down neo-vascularization.
2. The TuMOr AnGIOGeneSIS MOdelS
Cancer is a complicated phenomenon, which arises due to interactions between 
cells and several biochemical substances. Tumor growth may be studied in two 
different phases: Avascular phase-the initial phase, and the Vascular  phase-in 
which the tumor tries to recruit blood supply from the main blood stream. 
This process of formation of blood vessels is called angiogenesis, which is 
necessary for cancer cells to proliferate and spread to various body parts. The 
tumor secretes a chemical into the surrounding host tissue, which causes the 
formation of blood capillaries. This chemical is called Tumor Angiogenesis 
Factor (TAF). Edelstein (1982) developed a fungal growth model, based on 
which Bryne and Chaplain (1995) developed their model for tumor induced 
neovascularisation. Here we discuss this model in detail, followed by a quick 
summary of the other two models.
MOdel-I
The process of angiogenesis takes place in the following three stages:
Continuous Models 
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1. The basal lamina degrades in response to TAF. 
2. The blood vessels are formed and are moved towards the tumor. 
3. The blood vessels penetrate the tumor.
The second stage of angiogenesis is most crucial for a tumor to obtain nutrients, 
proliferate and metastasize, and here we concentrate on this stage. This model 
describes the process of angiogenesis in terms of the following three variables.
c : representing the chemical substance that is secreted into the surrounding 
tissue by the tumor, also known as TAF.
ρ : denoting the vessel density. In response to TAF, the basal lamina 
degrades and capillary vessels are formed, which advance towards the tumor.
n : representing the tip density, i.e. the number of tips per unit cross sectional 
area in a plane perpendicular to the direction of motion. The vessels join 
together to form a closed network, for the blood circulation to occur. Tips are 
formed at the leading front. The tips advance further and finally penetrate the 
tumor after which this model is no longer valid.
We next describe the system of differential equations governing the model.
The equation for vessel density:








 n x  t x  t d, , ( )  
where ρ(x, t) is the capillary density in units of capillary length per unit area, 
n(x, t) is the tip density in units of tips per unit area, ν(x, t) is the velocity of 
the tips, and d(ρ)is the death rate of capillaries in units of capillary length per 
unit area per unit time.
Vascular decay is also a feature of tumor induced vascularization. Eddy 
and Cassarett (1973) observed that some of the debris from the breakdown of 
established vessels may be used to provide material for growth elsewhere. If 
it is assumed that a fixed proportion γ
1
 of branches are broken down in each 
time unit, then
 d =  γ ρ1
The equation for tip density n(x, t): is given by












where σ is the net tip creation rate in units of tips per unit area per unit time; 
the net tip creation rate is a balance between tip creation σ
c
 and tip annihilation 
σ
a
, in units of tips per unit area per unit time
In undisturbed state, the limbal vasculature consists of interconnected 
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TAF. Tip proliferation arises from secondary branching behind the leading tip 
density front. Once the migrating vasculature has advanced towards the tumor, 
tip proliferation at the leading vascular edge multiplies rapidly. We assume 
the existence of a critical TAF concentration c
P
 such that when c > c
P,
 the tip 
proliferation occurs. Following Bryne and Chaplain (1995), we have taken tip 





 H(c − c 
P
) nc , where α
1
 is the rate of secondary tip proliferation, per 
unit TAF concentration, per tip, when the TAF concentration is sufficiently 
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The first term of above equation is the contribution of secondary branching, 
with α
0
 the rate of appearance of tips per unit area per unit TAF concentration 
for a unit length of branch.
In the literature, three models of tip annihilation have been proposed, viz., 
tip-to-tip anastomosis, tip-to-branch anastomosis, and tip death due to over-
crowding.
Tip-to-branch anastomosis is necessary to create an interconnected network 
of vessels, for the blood flow to occur. Also, tip annihilation is dominant in 
area of high capillary density so as to prevent unnecessary growth.
Here we consider tip annihilation, due to tip-to-branch anastomosis, 
modeled as
 σ β ρa n=− 1  
where β
1
 is a constant, and has units of tips fused per unit density per unit 
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According to Edelstein (1982) model for fungal growth, the tip speed v is 
constant. However, there are evidences that the tip extension is influenced by 
the presence of TAF, see Balding and McElwain (1985). Therefore, the cell 
flux J consists of two terms, due to random motion and due to chemotaxis
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where µ
1 
is the motility coefficient, χ
1 
is the chemotactic coefficient. Thus, 
J = n ν implies
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where D is the diffusion coefficient of TAF and λ
1 
is the natural decay rat.
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To close the system defined above, we introduce boundary and initial conditions. 
At the tumor, TAF concentration = c 
0
 , tip density = 0. At the limbus, TAF 
concentration = 0, tip density decays exponentially to 0, vessel density decays 
exponentially to ρ
min
 at the rate k s-1 .
The vessel density at the limbus does not fall to zero, because from 
experiments in Paweletz and Knierim (1989), Stokes and Lauffenburger 
(1991), it is suggested that if the front advancing towards the tumor has to 
maintain contact with the limbus, then the vessel density at limbus must 
not fall below some value ρ
min
.
Consequently, the boundary and initial conditions are as follows:
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where ρ
L
 is the density of the limbal vessels, and L is the distance between the 
tumor and the nearest limbal vessels.
Further, this system is non – dimensionalised and for this purpose, the 




, which is the time for TAF to diffuse from 
the tumor to the limbus.
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According to Balding and McElwain (1985) and Folkman (1976), 14 days is the 
average time for vascularization to occur. Hence, following Bryne and Chaplain 
(1995), we take τ ∼ 3.5 days. If the distance between tumor and limbus is 3 mm, 
then this leads to an estimate of diffusion coefficient D ∼ 2.9 × 10−7 cm2 s−1.
The model discussed above takes into account the effect of TAF on the 
basal lamina and describes motion of capillary sprouts as a directed response 
towards the tumor.
MOdel II
The model of tumor induced angiogenesis, described above, however does 
not take into account the role of extracellular matrix in capillary formation. 
Further improvement in this work was made by Anderson and Chaplain (1998), 
and they developed the model of angiogenesis with focus on 3 variables : 
endothelial cells, TAF and fibronectin.
Fibronectin is a protein of the extracellular matrix and it plays an important 
role in cell adhesion (binding of a cell to a surface, extracellular matrix or 
another cell), growth, migration and differentiation.
Continuous Models 
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Interactions between the endothelial cells and the extracellular matrix are 
very important and directly affect cell migration.
Haptotaxis is the directed response of endothelial cells in a fibronectin field.
Thus, the motion of endothelial cells is influenced by 3 factors: random 
motility, haptotaxis and chemotaxis (in response to TAF).
∴ The endothelial cell flux J
n
 is given by:
 J J J Jn random chemo hapto= + +  
Here, n denotes the endothelial cell density per unit area, c, the TAF 
concentration, and f, the fibronectin concentration.
J D nrandom n=− ∇ , where Dn is a positive constant, the cell random motility 
coefficient.








In Model-I, χ(c) was taken as a constant. The form of χ(c) here suggests 
that chemotactic sensitivity decreases when concentration of TAF increases.
The effect of fibronectin on the endothelial cells is modeled by the 
haptotactic flux:
 J n f, wherehapto = ∇ >ρ ρ0 0 0  






















The complete system describing the interactions of the endothelial cells, TAF 
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The capillary sprouts remain within the domain of tissue under consideration, 
and so the boundary condition takes the form:
ζ χ ρ.( ( ( ) ))− ∇ + ∇ + ∇ =D n n c c fn 0 0 , where ζ  is outward unit normal vector.
The initial conditions have been taken as:
(a) If the tumor is approximately circular and TAF diffuses into the 
extracellular matrix, then the TAF concentration field may be of the form:

























where ν is a positive constant and r is given by
 r x y= − + −( ) ( )1
1
2
2 2  
assuming the tumor is centered on (1,1/2), with a radius of 0.1.
It is worth mentioning that the equation and initial condition for TAF is 
essentially the same in the previous model and this model. In the previous 
model, the diffusion of TAF in the extracellular matrix was taken care of in 
the equation itself and in this model, it is assumed that the TAF has already 
diffused into the extracellular matrix, and initial TAF profile is as given above. 
The initial TAF profile for a larger tumor implant is:
c x,y e x y
x
( , ) ,( , ) [ , ] [ , ]
( )







 is a positive constant.
Both these forms of initial TAF concentration represent decrease in TAF 
concentration as the distance from the tumor increases.
It is assumed that presence of TAF field leads to rupturing of basal lamina, 
and plasma fibronectin leaks into the extracellular matrix, and thus, there is 
high concentration of fibronectin near the parent basal lamina. Thus, the initial 
fibronectin concentration is taken as:
f x y ke x y
x
( , , ) ,( , ) [ , ] [ , ]0 0 1 0 1
2
2= ∈ ×ε  where k < 1, ε
2
 are positive constants.





3 2 6ε sin ( )π  
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This model takes into consideration TAF and fibronectin (a Matrix Metallo 
Protein), and under the effect of these two, the directional migration of 
capillaries towards the tumor occurs.
MOdel -III
In another recent work by Travasso et al. (2011), the authors have considered 
the effect of all pro-angiogenic and anti-angiogenic factors, and have modeled 







c ci i i c i.( ( ) )D r β ρΗ(ρ), 
where c
i
 represents a growth factor, which is the balance between pro and anti-
angiogenesis factors.
The first term of this equation represents migration of growth factor c
i
 as 
a result of diffusion.
β
c
 is the rate of consumption by endothelial cells of c, the sum of the 
concentrations of all angiogenic factors considered.
H is the Heavyside function.
ρ describes the cells capable of proliferation, but not activated as yet. 
It takes the value −1 outside the capillary and +1 inside it. In areas of high 
proliferation of endothelial cells, the value of ρ is greater than one.
It is assumed that capillaries are formed as a result of endothelial cell 
proliferation ( in response to c
i
 ) and as a result of directed migration towards 
the tumor (here termed as interface dynamics).






= ∇ − + − ∇ +
ρ
ρ ρ ε ρ α ρ ρ2 3 2[ ] ( ) ( ),  
where M is the mobility coefficient of the endothelial cells.
There is a critical value of c, here denoted by c
P
 i.e. above which proliferation 
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ε denotes the width of the capillary vessels.
Tip Velocity: Velocity of the activated cells is modeled as:
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where χ is the chemotactic response of the endothelial cells.
For G > G 
M,




, being a 
critical value of gradient of c.
Endothelial cell activation occurs at points with large values of both c and ρ.
For activated cells to move, there must be some minimum value of G above 
which the cell motion occurs.
Based on experimental evidence and mathematical calculations, the 
authors made the observation that the increase of endothelial cell proliferation 
leads to an increase of the branch density and vessel density. For low 
proliferation rates, the vessels are very thin and rarely thick enough for a tip 
cell to emerge.
Thus, the process of angiogenesis is the result of a delicate balance between 
proliferation and chemotaxis, and various patterns observed in different 
experiments is due to variations in concentrations of TAF and MMPs in the 
ECM.
Here, we have discussed three models of tumor-induced angiogenesis, and 
all these models describe the process of neovascularization under the effect 
of three essential components viz. Tumor Angiogenesis Factor(TAF); Matrix 
Metalloproteins(MMPs),present in the ECM that stimulate angiogenesis, 
fibronectin being one of them; and directed response of endothelial cells 
towards the tumor, being modeled as random flux in the above models.
All models depict essentially the same features of the process with 
minor differences. The third model also takes into account the microscopic 
details of vessel thickness and capillary diameter in cases of high and low 
proliferation.
Model-I also discusses in detail secondary branching and secondary 
tip proliferation, above a critical value of TAF, which is necessary for 
neovascularization.
We feel that Model-I captures all the macroscopic features of the process 
of angiogenesis. We perform numerical simulations of this model.
3 nuMerICAl SIMulATIOnS
We have carried numerical simulations of this system of equations using 
Mathematica 7.0. In all figures presented below, the tumor is located at x = 0 
and limbus at x = 1.
In figures 1(a), (b), (c), we have shown tip density and vessel density 
responding to TAF, in case of successful angiogenesis.
We have taken parameters as:
 µ =0.001,χ=0.4, β= 50, = 0.2, λ =1, α =10, α =50, γ = 0.25.cp 1 0  
Continuous Models 
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Figure 1(a): Tip density in case of successful angiogenesis
Figure 1(b): Vessel density in case of successful angiogenesis
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In these figures, we have considered secondary tip proliferation which is 
necessary for angiogenesis.
In figures 2(a), (b) we have shown tip density profile and vessel density 
profile in case the parameters λ and c 
P
 are increased to λ = 10 and c
P
 = 0.5, 
other parameters remaining the same.
Note that c
P
 is the critical TAF concentration, such that secondary 
tip proliferation occurs when c > c
P
. As is clear from the figures below, 
neovascularization does not take place in this case.
These figures indicate that the presence of TAF plays a significant role in 
neovascularization.
Figure 2(a): Tip density in case of unsuccessful angiogenesis
Figure 2(b): Vessel density in unsuccessful angiogenesis
Continuous Models 
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In next simulations, we have taken secondary tip proliferation rate α
1
 = 0, 
taking other parameters as in Figure 1. We note that in this case vascularization 
does take place, although at a slower rate.
Figure 2(c): TAF concentration in unsuccessful angiogenesis
Figure 3(a): Tip density without secondary tip proliferation
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All the figures shown above explain the behavior of vasculature in three 
different cases of successful angiogenesis, unsuccessful angiogenesis, and 
slow angiogenesis. In figure 1(a), we see the tip profile advancing towards 
the tumor at x = 0. The tip number multiplies very fast at the leading edge, as 
the vasculature advances towards the tumor. The vessel density in figure 1(b) 
also follows a similar pattern. Thus, the strong presence of a TAF field, and 
secondary tip proliferation leads to successful angiogenesis.
In figure 2(b), the effect of a weak TAF field is evident, with tip density 
decaying very fast, as is the case with vessel density in figure 2(b). Clearly, the 
tips and the vessels do not reach tumor at x = 0, resulting in an unsuccessful 
angiogenesis. The increase in decay rate of TAF from λ
1
 = 1 in figure 1(c) to 
λ1 = 10 in figure 2(c) led to weakening of the underlying TAF field, which 
is responsible for unsuccessful angiogenesis. An increase in critical TAF 
concentration c 
P
 from 0.2 in figures 1(a), 1(b), and 1(c), to c
P
= 0.5 in figures 
2(a), 2(b), and 2(c), is also responsible for the unsuccessful angiogenesis. For 
c < 0.5, there was no secondary tip - proliferation. These two factors combined 
together resulted in the tumor not getting the blood supply.
Figure 3(a) and 3(b) show slow angiogenesis. This corresponds to the case 
when we have taken rate of secondary tip proliferation α
1
 = 0. Comparing 
figure 1(a) and figure 3(a), we find that secondary tip proliferation in 1(a) led 
to very fast vascularisation, while in absence of secondary tip proliferation, in 
figure 3(a), (b) the tips and vessels do reach the tumor at x = 0, but at a very 
slow rate, and the vessel density and tip density is also less when compared to 
1(a) and 1(b). Thus, secondary tip proliferation acts as a catalyst in the process 
of angiogenesis.
4 AnTI-AnGIOGeneSIS STrATeGY
Having studied the process of angiogenesis in detail, we will now discuss the 
anti- angiogenesis methods. We know that angiogenesis is critical for tumor 
development, growth and metastasis. There are several proteins in the body that 
stimulate angiogenesis, viz. The Vascular Endothelial Growth Factor(VEGF), 
Fibroblast Growth Factor(FGF) and Platelet Derived Growth Factor (PDGF) 
and their tyrosine kinase receptors are major regulators of angiogenesis.
VEGF is a signal protein produced by cells that stimulates angiogenesis. 
VEGF’s function is to create new blood vessels during embryo development, wound 
healing and formation of new blood vessels to compensate for blocked vessels. 
Expression of VEGF is necessary for a tumor to achieve neo-vascularization.
FGF and PDGF are also growth factors that play a significant role in the 
process of angiogenesis.
Continuous Models 
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Tyrosine kinase is an enzyme, that acts as a regulator in many cellular 
functions. Tyrosine kinase phosphorylation and dephosphorylation regulate 
many cellular pathways.
Drugs have been made that target the process of angiogenesis. Anti-
angiogenesis strategy plays a crucial role in cancer treatment. While 
chemotherapy has side effects as it affects normal cells since most 
chemotherapeutic drugs are DNA synthesis inhibitors resulting in side-affects, 
anti-angiogenesis treatment has no major known side effects, provided the 
level of drug in the blood does not exceed the prescribed safe limit.
The drugs are taken either orally, or intravenously.
Drug- decay from blood is a first order process, with decay rate being:
dC
d t
k C=−  where C(t) is the concentration of drug at time t, and k is the 
elimination constant
The elimination constant k is related to the half- life T1
2









Hence, drugs with longer half life stay in the blood stream for longer durations.
These facts may help in designing effective dose amount and schedule.
Several drugs have been identified for their anti-angiogenesis activity.
Here, we discuss 4 recent drugs that are being investigated for their role in 
cancer treatment:
a)  SU6668 : SU6668 is a tyrosine kinase inhibitor which targets VEGF, 
FGF and PDGF.
  The drug is given orally, and its half-life is approximately 1 hour in 
humans (Britten et al. 2002).
  The drug is well tolerated at 200 mg/m2 .
  SU6668 was found to display significant anti-angiogenesis potential in 
a study (Klenke and Abdollahi, 2007) performed on 10 male severe 
immunodeficient mice. The authors concluded that SU6668 can induce 
growth inhibition of various primary tumors.
b)  Vandetanib (ZD6474) : Vandetanib is a dual inhibitor of VEGF and 
Epidermal Growth Factor Receptor (EGFR) (Morabito, 2009). It is 
taken orally, and it inhibits intracellular signaling pathways involved 
in tumor growth, progression and angiogenesis.
 Maximum tolerated dose is 300 mg.
  ZD6474 has half life of more than 100 hours and a minimum of 28 
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  It has been found that Vandetanib is a selective inhibitor of VEGF and 
EGF- stimulated cell proliferation.
c)  BMS-690514: It is a VEGFR and EGFR tyrosine kinase inhibitor, and 
it has been observed that combining it with radiation could improve 
the prognosis of tumor (Bahleda, 2008).
 Maximun tolerated dose is 200 mg.
 Half – life is approximately 11 hours.
d)  Bevacizumab (Avastin): It is the most widely used drug for slowing 
down the process of angiogenesis. It inhibits VEGF-A, a chemical 
that stimulates angiogenesis. It is licensed to treat various kinds of 
metastatic cancers (Wikipedia).
  Recommended dose is 5mg/kg to 10mg/kg every 2 weeks, or 7.5 mg/
kg to 15 mg/kg to be given once every 3 weeks.
 It is given intravenously.
 It has a long half life of 20 days (range 11-50 days).
  It is important to note that elimination constant of a drug varies 
according to age, and is smaller for old or sick people. When a drug 
is introduced, it is first tested on animals, followed by clinical trials. 
We suggest the use of mathematical modeling and simulations in 
designing effective dose schedule. Such simulations may be patient 
specific, taking into account their age, sex and any other ailments. 
The aim of a effective dose schedule is to keep the level of drug in the 
blood above a effective level and below the safety threshold.
Here we have performed simulations for the drug Avastin, for a 60 Kg male.
In all the figures above, the level of drug settles to a constant concentration 
after about 7-8 doses. It is also to be noted that the amount of drug that 
reaches the blood stream depends on the mode of drug delivery. For a drug 
(a) Concentration of Avastin in blood when 5mg/Kg are given after every 2 
weeks
Continuous Models 
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(b) Concentration of Avastin in blood when 5mg/Kg are administered after 
every 3 weeks
(c) Concentration of Avastin in blood when 7.5 mg/Kg are given after every 2 
weeks
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given intravenously, the entire drug reaches the blood stream instantly. In oral 
delivery, some amount of the drug is lost in absorption while passing through 
the food tract system. Effective and optimal drug delivery schedules may be 
designed with the help of these facts.
5. COnCluSIOnS
While making models for biological or physical processes, two important 
points that need to be worked out are the parameters estimation and of course, 
the solution (analytical or numerical) of the resultant mathematical model. 
While parameters estimation requires experimental evidence, obtaining the 
solution of the model correctly has been an area of active research where the 
obvious aim is to solve the system effectively. Here, we have studied three 
models of angiogenesis and solved one such model using Mathematica. We 
have carried out numerical simulations in three cases: successful angiogenesis, 
with secondary tip proliferation, unsuccessful angiogenesis, and angiogenesis 
without secondary tip proliferation. The figures presented earlier clearly 
demonstrate these cases.  The presence of a powerful graphical interface 
helped us to visualize the behavior of tips and vessels in a very clear way, such 
that one needed no expertise to understand, something which was not possible 
in earlier studies reported in literature. We further identified the signaling 
factors of angiogenesis, and the drugs that target these factors. It is suggested 
that optimal drug dose, schedule and mode of delivery can be worked out for 
different kinds of tumors and for individual patients for better results along 
with radiation etc. with the help of mathematical simulations.
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